The biotech sector is reaching a turning point as development-stage companies are maturing, with drugs gaining approvals and generating revenue, leading to increased profitability and attracting more generalist investor interest, supported by optimistic financial forecasts through 2030.
The latest U.S. jobs report reveals concerning trends including a slowdown in job creation since April, rising Black unemployment, growth concentrated in health and social services sectors, significant manufacturing job losses, and a surge in teen unemployment, indicating potential ongoing challenges in the labor market.
US unemployment rose to 4.6% in November, the highest since 2021, amid a cooling labour market with job losses in government and manufacturing sectors, but gains in healthcare and construction, reflecting ongoing economic uncertainty and policy impacts.